Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes

被引：40

作者：

von Eiff, C

Friedrich, AW

Becker, K

Peters, G

机构：

[1] Univ Munster, Hosp & Clin, Inst Med Microbiol, D-48149 Munster, Germany

[2] Univ Munster, Hosp & Clin, Inst Hyg, D-48149 Munster, Germany

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 10期

关键词：

D O I：

10.1128/AAC.49.10.4372-4374.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The antistaphylococcal activity of ceftobiprole was compared with those of cefuroxime, linezolid, and moxifloxacin by using the agar dilution method. Apart from three strains with small-colony variant phenotypes, all Staphylococcus aureus isolates tested were inhibited by <= 2 mu g/ml of ceftobiprole. This compound exhibited an excellent antistaphylococcal activity, comparable to that of linezolid.

引用

收藏

页码：4372 / 4374

页数：3

相关论文

共 14 条

[1] Physiology and antibiotic susceptibility of Staphylocoecus aureus small colony variants [J].

Baumert, N ;

Von Eiff, C ;

Schaaff, F ;

Peters, G ;

Proctor, RA ;

Sahl, HG .

MICROBIAL DRUG RESISTANCE, 2002, 8 (04) :253-260

[2] Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species [J].

Becker, K ;

Harmsen, D ;

Mellmann, A ;

Meier, C ;

Schumann, P ;

Peters, G ;

von Eiff, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (11) :4988-4995

[3] Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus [J].

Chambers, HF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :884-888

[4]

*CSLI, 2005, M100S15 CLSI

[5] Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates [J].

Deshpande, L ;

Rhomberg, PR ;

Fritsche, TR ;

Sader, HS ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) :73-75

[6] Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management [J].

Harmsen, D ;

Claus, H ;

Witte, W ;

Rothgänger, J ;

Claus, H ;

Turnwald, D ;

Vogel, U .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) :5442-5448

[7] In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci [J].

Hebeisen, P ;

Heinze-Krauss, I ;

Angehrn, P ;

Hohl, P ;

Page, MGP ;

Then, RL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :825-836

[8] In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci [J].

Jones, RN ;

Deshpande, LM ;

Mutnick, AH ;

Biedenbach, DJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) :915-932

[9] Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus [J].

Kipp, F ;

Becker, K ;

Peters, G ;

von Eiff, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) :1277-1279

[10] IDENTIFICATION OF METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI BY POLYMERASE CHAIN-REACTION [J].

MURAKAMI, K ;

MINAMIDE, W ;

WADA, K ;

NAKAMURA, E ;

TERAOKA, H ;

WATANABE, S .

JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) :2240-2244